Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Robbins

Showing results (251-260 of 331) with videos related to

Pageof 34
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2009
Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384Gregory K Robbins, John G Spritzler, Ellen S Chan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 6, 2009
Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjectsGail Skowron, John G Spritzler, Jodi Weidler, et al.
Clinical Chemistry|March 26, 2003
Comparison of two CYP2D6 genotyping methods and assessment of genotype-phenotype relationshipsWen-Hwei Chou, Feng-Xiang Yan, Doris K Robbins-Weilert, et al.
The Journal of Infectious Diseases|April 21, 2010
African mitochondrial DNA subhaplogroups and peripheral neuropathy during antiretroviral therapyJeffrey A Canter, Gregory K Robbins, Doug Selph, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 19, 2002
Coronary risk stratification in patients with end-stage lung diseaseAditya K Kaza, Jeffrey F Dietz, John A Kern, et al.
The Journal of Clinical Endocrinology and Metabolism|September 26, 2017
HDL Cholesterol Efflux Capacity in Newly Diagnosed HIV and Effects of Antiretroviral TherapyMabel Toribio, Min Hi Park, Markella V Zanni, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2005
Pharmacokinetics of nelfinavir and efavirenz in antiretroviral-naive, human immunodeficiency virus-infected subjects when administered alone or in combination with nucleoside analog reverse transcriptase inhibitorsPatrick F Smith, Gregory K Robbins, Robert W Shafer, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|December 2, 2010
Use of biological knowledge to inform the analysis of gene-gene interactions involved in modulating virologic failure with efavirenz-containing treatment regimens in ART-naïve ACTG clinical trials participantsBenjamin J Grady, Eric S Torstenson, Paul J McLaren, et al.
HIV Clinical Trials|June 28, 2016
Characteristics associated with virologic failure in high-risk HIV-positive participants with prior failure: a post hoc analysis of ACTG 5251Gregory K Robbins, Susan E Cohn, Linda J Harrison, et al.
Open Forum Infectious Diseases|November 2, 2020
Effects of Integrase Inhibitor-Based ART on the NLRP3 Inflammasome Among ART-Naïve People With HIVMabel Toribio, Tricia H Burdo, Evelynne S Fulda, et al.
Pageof 34

Showing results (251-260 of 331) with videos related to

Sort By:
Pageof 34
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2009
Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384Gregory K Robbins, John G Spritzler, Ellen S Chan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 6, 2009
Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjectsGail Skowron, John G Spritzler, Jodi Weidler, et al.
Clinical Chemistry|March 26, 2003
Comparison of two CYP2D6 genotyping methods and assessment of genotype-phenotype relationshipsWen-Hwei Chou, Feng-Xiang Yan, Doris K Robbins-Weilert, et al.
The Journal of Infectious Diseases|April 21, 2010
African mitochondrial DNA subhaplogroups and peripheral neuropathy during antiretroviral therapyJeffrey A Canter, Gregory K Robbins, Doug Selph, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 19, 2002
Coronary risk stratification in patients with end-stage lung diseaseAditya K Kaza, Jeffrey F Dietz, John A Kern, et al.
The Journal of Clinical Endocrinology and Metabolism|September 26, 2017
HDL Cholesterol Efflux Capacity in Newly Diagnosed HIV and Effects of Antiretroviral TherapyMabel Toribio, Min Hi Park, Markella V Zanni, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2005
Pharmacokinetics of nelfinavir and efavirenz in antiretroviral-naive, human immunodeficiency virus-infected subjects when administered alone or in combination with nucleoside analog reverse transcriptase inhibitorsPatrick F Smith, Gregory K Robbins, Robert W Shafer, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|December 2, 2010
Use of biological knowledge to inform the analysis of gene-gene interactions involved in modulating virologic failure with efavirenz-containing treatment regimens in ART-naïve ACTG clinical trials participantsBenjamin J Grady, Eric S Torstenson, Paul J McLaren, et al.
HIV Clinical Trials|June 28, 2016
Characteristics associated with virologic failure in high-risk HIV-positive participants with prior failure: a post hoc analysis of ACTG 5251Gregory K Robbins, Susan E Cohn, Linda J Harrison, et al.
Open Forum Infectious Diseases|November 2, 2020
Effects of Integrase Inhibitor-Based ART on the NLRP3 Inflammasome Among ART-Naïve People With HIVMabel Toribio, Tricia H Burdo, Evelynne S Fulda, et al.
Pageof 34